AbCellera Biologics Inc.
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, AI-powered drug discovery platform searches and analyzes the database of natural immune systems to find antibodies that can be developed as drugs. The company also develops next-generation transgenic mice that provide a source of fully-human antibodies for the discovery of therapeutic antibody candidates. It has a discovery partnership agreement with Eli Lilly and Company for the discovery of various targets. AbCellera Biologics Inc. was founded in 2012 and is headquartered in Vancouver, Canada. Show More...
-
Website http://www.abcellera.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 2.02 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -0.010 Dividends USD Payout Ratio % * Shares Mil 172.0 172.0 172.0 Book Value Per Share * USD 3.09 Free Cash Flow Per Share * USD Return on Assets % 1.36 -9.83 -0.2 Financial Leverage (Average) 5.3 8.68 1.6 Return on Equity % 7.2 -65.42 -0.32 Return on Invested Capital % 5.56 -25.23 3.38 Interest Coverage 2.45 -9.57 1.06 Current Ratio 2.36 1.6 5.67 Quick Ratio 2.27 1.51 5.53 Debt/Equity 0.22 1.48 0.06